Close Menu
May 12, 2021
Sponsored by
Combinati

SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19

GenomeWebinar

Postdoctoral Research Fellow, Emergency Surgery
Stanford University School of Medicine

This webinar will discuss a recent study that characterized the relationships between SARS-CoV-2 RNAemia and disease severity, clinical deterioration, and extrapulmonary complications (EPCs).

While the determinants of COVID-19 disease severity and EPCs are poorly understood, the varied clinical manifestations of COVID-19 have directed attention to the distribution of SARS-CoV-2 in the body. Although SARS-CoV-2 RNA is most concentrated in the nasopharynx, it has also been found in numerous other tissues, raising questions about dissemination of viral RNA throughout the body as well as the role of this process in disease severity and extrapulmonary complications.  Recent studies have detected low levels of SARS-CoV-2 RNA in blood and have associated RNAemia with disease severity and biomarkers of dysregulated immune response. 

In this webinar, Dr. Nikhil Ram Mohan, a postdoctoral scholar in the Department of Emergency Medicine at Stanford University, will discuss a study that used an array-based dPCR platform to detect and quantify SARS-CoV-2 RNA in specimens collected from the nasopharynx and from plasma of patients diagnosed with COVID-19.

He will discuss how variation in SARS-CoV-2 RNAemia may help explain disparities in disease severity and EPCs from COVID-19 as well as how using digital PCR to test for RNAemia early in the course of illness may help guide patient triage and management.

Sponsored by

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.

May
05
Sponsored by
Illumina

Adverse drug reactions (ADRs) are responsible for around 5 percent of hospital admissions and occur in 6 percent to 15 percent of hospital stays.

May
12
Sponsored by
Combinati

This webinar will discuss a recent study that characterized the relationships between SARS-CoV-2 RNAemia and disease severity, clinical deterioration, and extrapulmonary complications (EPCs).